Prot#R668-AD-2024: Neuropsychologic Assessment of Dupilumab-Treated Adolescents with Moderate-to-Severe Atopic Dermatitis

Project: Research project

Project Details

StatusActive
Effective start/end date4/19/224/19/25

Funding

  • ICON Clinical Research Limited (Prot#R668-AD-2024)
  • Regeneron Pharmaceuticals, Inc. (Prot#R668-AD-2024)